Lynne Brum
Investor Relations Kontakt bei YIELD10 BIOSCIENCE, INC.
Vermögen: 9 560 $ am 30.04.2024
Aktive Positionen von Lynne Brum
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
YIELD10 BIOSCIENCE, INC. | Investor Relations Kontakt | - | - |
Public Communications Contact | 01.11.2011 | - | |
Unternehmenssekretär | - | - | |
Vertrieb & Marketing | 01.11.2011 | - |
Karriereverlauf von Lynne Brum
Ehemalige bekannte Positionen von Lynne Brum
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Seidler Bernstein, Inc.
Seidler Bernstein, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kelley Habib John, Seidler Bernstein, Inc. is a provider of healthcare marketing communications services. The company is based in Cambridge, MA. Seidler Bernstein was acquired by Kelley Habib John on February 14, 2011. | Corporate Officer/Principal | 01.01.2010 | 01.01.2011 |
Porter Novelli Life Sciences LLC
Porter Novelli Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Porter Novelli Life Sciences LLC provides services such as investor and media relations, as well as product launches. The private company is based in San Diego. | Corporate Officer/Principal | 01.01.2007 | 01.01.2009 |
VERTEX PHARMACEUTICALS INCORPORATED | Public Communications Contact | 01.01.1994 | - |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | - | 09.06.2006 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Public Communications Contact | - | - | |
Feinstein Kean Healthcare
Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Feinstein Kean Healthcare is a private company that provides strategic communications consulting services. The company is based in Cambridge, MA. | Corporate Officer/Principal | - | - |
Ausbildung von Lynne Brum
Simmons University | Masters Business Admin |
Wellesley College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Operativ
Public Communications Contact | 3 |
Corporate Officer/Principal | 3 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 4 |
Commercial Services | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
YIELD10 BIOSCIENCE, INC. | Process Industries |
Private Unternehmen | 5 |
---|---|
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Feinstein Kean Healthcare
Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Feinstein Kean Healthcare is a private company that provides strategic communications consulting services. The company is based in Cambridge, MA. | Commercial Services |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Seidler Bernstein, Inc.
Seidler Bernstein, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kelley Habib John, Seidler Bernstein, Inc. is a provider of healthcare marketing communications services. The company is based in Cambridge, MA. Seidler Bernstein was acquired by Kelley Habib John on February 14, 2011. | Commercial Services |
Porter Novelli Life Sciences LLC
Porter Novelli Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Porter Novelli Life Sciences LLC provides services such as investor and media relations, as well as product launches. The private company is based in San Diego. | Commercial Services |
- Börse
- Insiders
- Lynne Brum
- Erfahrung